Merz Pharma GmbH & Co KgaA:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Merz Pharma GmbH & Co KgaA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0153
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Merz Pharma GmbH & Co KgaA (Merz Pharma) is an aesthetics and neurotoxin company that develops products for aesthetic and medical dermatology and neurological movement disorders. The company’s products include aesthetics, ethical drugs, over-the-counter drugs, neurology, and central nervous system, skin and hair care, vitamins and minerals, and dental devices. It offers products for various therapeutic areas such as Alzheimer’s disease, depression, dystonia, hair loss, liver diseases, Parkinson’s disease, cold, scars, wrinkles and other skin disorders. The company also offers vitamins and minerals, and hygienic products for medical disinfection and cleaning. It operates in Australia, Switzerland, Spain, France, the US and the UK, among others. Merz Pharma is headquartered in Frankfurt am Main, Germany.

Merz Pharma GmbH & Co KgaA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Merz Pharma GmbH & Co KgaA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deal Details 10
Venture Financing 10
Cytrellis Biosystems Raises USD28.5 Million in Series B Financing 10
Cytrellis Biosystems Raises Funds through Venture Financing 11
Cabochon Aesthetics Raises US$0.4 Million In Venture Financing 12
Partnerships 13
Merz Pharma Enters into Distribution Agreement with Ulthera 13
Equity Offering 14
Ulthera Withdraws IPO 14
Acquisition 15
Merz North America Acquires ON Light Sciences 15
Shofu to Acquire Merz Dental from Merz Pharma for USD19 Million 16
Merz Pharma Completes Acquisition of Ulthera for USD600 Million 17
Ulthera Acquires Cabochon Aesthetics, Minimally Invasive Treatments Provider 18
Merz Pharma Acquires Anteis, Aesthetics Company 19
Merz Pharma Acquires Neocutis, Dermatology Company 20
Merz Pharma GmbH & Co KgaA – Key Competitors 21
Merz Pharma GmbH & Co KgaA – Key Employees 22
Merz Pharma GmbH & Co KgaA – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Corporate Communications 25
Apr 04, 2017: Merz Appoints Bob Rhatigan as President and Chief Executive Officer in North America 25
Product News 26
May 18, 2017: Merz Celebrates a Monumental Milestone: One Million Treatments Worldwide With Ultherapy 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Merz Pharma GmbH & Co KgaA, Medical Equipment, Key Facts 2
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Merz Pharma GmbH & Co KgaA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Merz Pharma GmbH & Co KgaA, Deals By Market, 2012 to YTD 2018 8
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cytrellis Biosystems Raises USD28.5 Million in Series B Financing 10
Cytrellis Biosystems Raises Funds through Venture Financing 11
Cabochon Aesthetics Raises US$0.4 Million In Venture Financing 12
Merz Pharma Enters into Distribution Agreement with Ulthera 13
Ulthera Withdraws IPO 14
Merz North America Acquires ON Light Sciences 15
Shofu to Acquire Merz Dental from Merz Pharma for USD19 Million 16
Merz Pharma Completes Acquisition of Ulthera for USD600 Million 17
Ulthera Acquires Cabochon Aesthetics, Minimally Invasive Treatments Provider 18
Merz Pharma Acquires Anteis, Aesthetics Company 19
Merz Pharma Acquires Neocutis, Dermatology Company 20
Merz Pharma GmbH & Co KgaA, Key Competitors 21
Merz Pharma GmbH & Co KgaA, Key Employees 22
Merz Pharma GmbH & Co KgaA, Other Locations 23
Merz Pharma GmbH & Co KgaA, Subsidiaries 23

List of Figures
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Merz Pharma GmbH & Co KgaA:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Coffee Republic Trading Ltd:企業の戦略・SWOT・財務情報
    Coffee Republic Trading Ltd - Strategy, SWOT and Corporate Finance Report Summary Coffee Republic Trading Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Soitec SA (SOI)-エネルギー分野:企業M&A・提携分析
    Summary Soitec S.A. (Soitec) is a designer and manufacturer of semiconductor materials. The company offers solutions for miniaturizing chips. Its products are used to manufacture chips which are used in smartphones, tablets, computers, IT servers and data centers, electronic components in cars, conn …
  • Ocugen Inc (OCGN):企業の財務・戦略的SWOT分析
    Summary Ocugen Inc (Ocugen), formerly Histogenics Corp, is a biopharmaceutical company that discovers, develops and commercializes transformative drugs for the treatment of eye diseases. The company’s lead product candidate, OCU300, is a small molecule therapeutic intended for the treatment of ocula …
  • Sohu.com Ltd. (SOHU):企業の財務・戦略的SWOT分析
    Sohu.com Ltd. (SOHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hyundai Motor Company:企業の戦略・SWOT・財務情報
    Hyundai Motor Company - Strategy, SWOT and Corporate Finance Report Summary Hyundai Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Tel Aviv Sourasky Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Tel Aviv Sourasky Medical Center (Sourasky Medical) is an academic medical center that provides patient-centered care, research and education services. The center offers services in the areas of cardiology, dermatology, gastroenterology, general surgery, genetics, emergency medicine, rheumat …
  • Sumitomo Corp (8053):企業の財務・戦略的SWOT分析
    Sumitomo Corp (8053) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Time Dotcom Berhad (TIMECOM):企業の財務・戦略的SWOT分析
    Time Dotcom Berhad (TIMECOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Schindler Holding Ltd (SCHP):企業の財務・戦略的SWOT分析
    Schindler Holding Ltd (SCHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Gateway Lifestyle Group:企業の戦略・SWOT・財務情報
    Gateway Lifestyle Group - Strategy, SWOT and Corporate Finance Report Summary Gateway Lifestyle Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Marathon Oil Corporation:企業の戦略・SWOT・財務分析
    Marathon Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Marathon Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sinclair Pharma Ltd:企業の製品パイプライン分析
    Summary Sinclair Pharma Ltd (Sinclair), formerly Sinclair Pharma plc, is an aesthetics company, which provides dermatological solutions. The company develops, manufactures and distributes dermatological products for facial aesthetics, particularly for facial rejuvenation, through collagen stimulatio …
  • Lassonde Industries Inc.:戦略・SWOT・企業財務分析
    Lassonde Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Lassonde Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • EBSCO Industries Inc:企業の戦略的SWOT分析
    EBSCO Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Theralase Technologies Inc (TLT):医療機器:M&Aディール及び事業提携情報
    Summary Theralase Technologies Inc (Theralase Technologies) is a biopharmaceutical company that manufactures, designs, and develops laser and laser technology for companion animal, human, and equine applications. The company offers products such as multiple probe, controller, multiple probe, triple …
  • Ability Pharmaceuticals SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Ability Pharmaceuticals SL (Ability Pharma), formerly AB Therapeutics SL is a biopharmaceutical company that discovers and develops human therapeutics for the treatment of cancer and other indications. The company’s lead pipeline drug candidate includes ABTL0812, a new drug class of small mo …
  • Oriental Bank of Commerce:企業の戦略・SWOT・財務分析
    Oriental Bank of Commerce - Strategy, SWOT and Corporate Finance Report Summary Oriental Bank of Commerce - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • PixarBio Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary PixarBio Corp (PixarBio), formerly BMP Holdings Inc is a biotechnology company that discovers and develops novel neurological drug delivery systems for postsurgical pain, acute pain, and chronic pain. The company offers research and commercial development of targeted drug delivery systems, b …
  • Shopper’S Stop Ltd.
    Shopper'S Stop Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shopper'S Stop Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PT. Matahari Putra Prima Tbk (MPPA):企業の財務・戦略的SWOT分析
    PT. Matahari Putra Prima Tbk (MPPA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆